AKT1 and cancer: Genes like EGF and SRC contribute to this metabolic shift by activating PI3K/AKT and MAPK signaling pathways, which enhance glucose uptake, lipid biosynthesis and amino acid metabolism-key hallmarks of cancer metabolism (Dosch et al., 2020).